Community/Retail

Fourth-year student Ashley Lam discussed how pharmacists and pharmacy students can get involved in environmental issues.

Semaglutide (Ozempic; Novo Nordisk) approved as a once-weekly subcutaneous injection for the treatment of adults with type 2 diabetes.

FDA approves the EVO/EVO+ Visian Implantable Collamer Lens for the correction of myopia and myopia with astigmatism.

Ibalizumab-uiyk (Trogarzo) is a CD4-directed post-attachment HIV-1 inhibitor.

Daily Fiber SF is used for digestive support and for stomach regularity.

The monotherapy demonstrates rapidly improved symptoms over 4 weeks for individuals with moderate-to-severe disease.

Johnson & Johnson’s Janssen Pharmaceutical Companies subsidiary’s post-hoc analysis of Tremfya demonstrates clinically significant improvements.

Study finds that the use of biologics and other potentially immunocompromising therapies for atopic dermatitis was associated with low risk of severe COVID-19.

Access to buprenorphine among Medicaid beneficiaries was not affected during the pandemic.

Curtailing the availability of meth precursors in the principal focus of the law, paving the way for states to follow suit.

Patients in the atogepant 60 mg daily and 30 mg twice daily treatment arms of the study experienced a decrease of 6.88 and 7.46 monthly migraine days, respectively.

Baricitinib (Olumiant; Eli Lilly and Incyte ) was found to produce significant hair regrowth on the scalp, eyelashes, and eyebrows of adults with severe alopecia areata.

Theraworx is a foam that offers relief from muscle cramps and spasm.

FDA seeks to reduce diversion of pharmaceutical products via sales by unlicensed distributers and tighten up the supply chain by vetting trading partners.

Students from the University of the Sciences Philadelphia College of Pharmacy and the Rutgers University Ernest Mario School of Pharmacy went head-to-head to answer questions about the pharmacy field.

Heat waves, which are on the rise, appear to pose particular cardiovascular risk for Black populations and men, new study results show.

In proposed changes, the practice would fall within nonsterile compounding.

FDA approves label update for Cabenuva that makes the therapy’s oral lead-in with cabotegravir and rilpivirine tablets optional.

RSVpreF gets breakthrough designation for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in individuals 60 years of age or older.

Most other compounds undergoing clinical trials target testosterone, which can lead to depression, higher low-density lipoprotein cholesterol levels, and weight gains.

Donepezil (Aricept) is an acetylcholinesterase inhibitor indicated for the treatment of dementia related to Alzheimer disease.

Pataday ophthalmic solution is an antihistamine that can help reduce itch and redness in the eyes.

Many of the medications used in the treatment of erectile dysfunction have interactions with other medications, so it is crucial for pharmacists to carefully examine patient profiles to optimize therapy and ensure safety.

Investigators also identified that a polymerase inhibitor with a unique modification largely resists its removal from the RNA by the exonuclease.

Thirty minutes of day of movement, such as walking, can help break the cycle of inflammation that causes symptoms even 6 months later.

Nasacort offers temporary relief of allergy symptoms, such as nasal congestion, sneezing, itchy and runny nose.

Patient-centered communication incorporates patients’ concerns, ideas, and abilities when developing a treatment plan.

The FDA recently approved cabotegravir 200 mg/mL and rilpivirine 300 mg/mL as a once-monthly treatment for adults with HIV-1 who are virologically suppressed on a stable antiretroviral regimen.